Division of Pediatric Urology, Department of Urology, University of Michigan, Ann Arbor, Michigan.
Dow Division of Health Services Research, Department of Urology, University of Michigan, Ann Arbor, Michigan.
J Urol. 2021 Jan;205(1):250-256. doi: 10.1097/JU.0000000000001314. Epub 2020 Jul 27.
Given the increasing prevalence of chronic kidney disease in people with spina bifida, we sought to determine if this is associated with an increase in end stage kidney disease. We examined population based data to measure the frequency of procedures to establish renal replacement therapy-a marker for end stage kidney disease-among patients with spina bifida.
We used the Healthcare Cost and Utilization Project State Inpatient Database and State Ambulatory Surgery and Services Database from Florida, Kentucky, Maryland and New York (2000 to 2014), which include encounter level data. With a diagnosis code based algorithm we identified all procedural encounters made by patients with spina bifida. We determined the percentage of these encounters that were for facilitating renal replacement therapy (ie arteriovenous anastomosis, renal transplantation). We assessed for changes over time in this percentage with the Cochran-Armitage trend test. Bivariate analysis was performed using chi-square test.
Of all procedures performed on patients with spina bifida over this time the proportion of procedures performed to establish renal replacement therapy significantly decreased in both the inpatient and outpatient settings (p=0.042 and p <0.001, respectively). People with spina bifida undergoing procedures to establish renal replacement therapy were, on average, young adults (mean age 34.5 and 36.0 years) with a high prevalence hypertension (75.8% of inpatients, 68.6% of outpatients).
The frequency of surgeries to initiate renal replacement therapy among people with spina bifida undergoing procedures is low and is not increasing. This highlights the importance of consistent care throughout adolescence and young adulthood, and hypertension screening.
鉴于脊柱裂患者慢性肾脏病的发病率不断上升,我们试图确定这是否与终末期肾病的增加有关。我们检查了基于人群的数据,以衡量脊柱裂患者接受建立肾脏替代治疗(终末期肾病的标志)的程序的频率。
我们使用了佛罗里达州、肯塔基州、马里兰州和纽约州的医疗保健成本和利用项目州住院数据库和州门诊手术和服务数据库(2000 年至 2014 年),其中包括遭遇水平数据。我们使用基于诊断代码的算法确定了所有接受脊柱裂治疗的患者的手术遭遇。我们确定了这些遭遇中有多少是为了促进肾脏替代治疗(即动静脉吻合术、肾移植)。我们使用 Cochran-Armitage 趋势检验评估这一百分比随时间的变化。使用卡方检验进行了双变量分析。
在此期间对所有脊柱裂患者进行的所有手术中,无论是在住院还是门诊环境下,用于建立肾脏替代治疗的手术比例均显著下降(p=0.042 和 p<0.001)。接受建立肾脏替代治疗的脊柱裂患者平均为年轻成年人(住院患者的平均年龄为 34.5 岁和 36.0 岁,门诊患者为 36.0 岁),高血压患病率很高(住院患者中 75.8%,门诊患者中 68.6%)。
接受手术的脊柱裂患者启动肾脏替代治疗的手术频率较低且没有增加。这突出了在整个青少年和成年早期保持一致护理以及高血压筛查的重要性。